Table 4. Adjusted coefficients of change for log10 HIV RNA levels from model excluding women who interrupted HAART (Model 2) (n=86, N=249) and from model excluding women who interrupted or modified HAART (Model 3) (n=65, N=181).
| Model 2 | Model 3 | |||
|---|---|---|---|---|
|
| ||||
| Coefficient# (95%CI) |
P | Coefficient# (95%CI) |
P | |
| Slope to delivery | −0.046 (−0.06, −0.03) | <0.0001 | −0.047 (−0.06, − 0.03) |
<0.0001 |
| Modified HAART regimen in pregnancy |
||||
| No | 0.00 | - | ||
| Yes | 0.27 (−0.09, 0.63) | 0.14 | - | |
| Race by IDU | ||||
| White non-IDU | 0.00 | |||
| Black non-IDU | 0.29 (−0.09, 0.67) | 0.14 | 0.49 (0.02, 0.95) | 0.04 |
| White IDU | −0.21 (−0.65, 0.23) | 0.34 | −0.09 (−0.62, 0.42) | 0.71 |
| Type of HAART regimen at conception |
||||
| PI-containing | 0.00 | 0.00 | ||
| NNRTI-containing | −0.41 (−0.76, −0.06) | 0.02 | −0.48 (−0.88, −0.07) | 0.02 |
| Duration of HAART at conception |
||||
| ≥ 15 months | 0.00 | 0.00 | ||
| 6-15 months | 0.08 (−0.36, 0.52) | 0.72 | 0.12 (−0.39, 0.64) | 0.63 |
| < 6 months | 0.16 (−0.22, 0.54) | 0.40 | 0.29 (−0.18, 0.76) | 0.22 |
| Baseline CD4 count (cells/mm3) |
||||
| ≥ 500 | 0.00 | 0.00 | ||
| 200-499 | 0.072 (−0.31, 0.46) | 0.72 | −0.02 (−0.44, 0.41), | 0.94 |
| <200 | 0.52 (0.014, 1.03) | 0.04 | 0.78 (0.16, 1.41) | 0.01 |
#
Adjusted for by time period and type of assay used